Biotechnology Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen October 7, 2020
Biotechnology BIOMARIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRN October 6, 2020
Biotechnology Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares October 6, 2020
Biotechnology INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm October 6, 2020
Biotechnology BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2 October 6, 2020
Biotechnology Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology October 6, 2020
Biotechnology argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships October 6, 2020
Biotechnology ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – CBMG, VRTU, MR, IMMU, JCAP October 5, 2020
Search
Biotechnology
